James V. Cassella
2020
In 2020, James V. Cassella earned a total compensation of $1.3M as Chief Development Officer at Concert Pharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,317 |
|---|---|
| Option Awards | $283,144 |
| Salary | $450,633 |
| Stock Awards | $306,708 |
| Other | $15,408 |
| Total | $1,281,210 |
Cassella received $450.6K in salary, accounting for 35% of the total pay in 2020.
Cassella also received $225.3K in non-equity incentive plan, $283.1K in option awards, $306.7K in stock awards and $15.4K in other compensation.
Rankings
In 2020, James V. Cassella's compensation ranked 7,547th out of 13,090 executives tracked by ExecPay. In other words, Cassella earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,547 out of 13,090 | 42nd |
Division Manufacturing | 3,177 out of 5,621 | 44th |
Major group Chemicals And Allied Products | 1,282 out of 2,254 | 43rd |
Industry group Drugs | 1,108 out of 1,954 | 43rd |
Industry Pharmaceutical Preparations | 826 out of 1,459 | 43rd |
Source: SEC filing on April 27, 2021.
Cassella's colleagues
We found two more compensation records of executives who worked with James V. Cassella at Concert Pharmaceuticals in 2020.